The Soluble Form of IL-1 Receptor Accessory Protein Enhances the Ability of Soluble Type II IL-1 Receptor to Inhibit IL-1 Action
Open Access
- 1 January 2003
- Vol. 18 (1) , 87-96
- https://doi.org/10.1016/s1074-7613(02)00514-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Single Amino Acid Difference between Human and Monkey Interleukin (IL)-1β Dictates Effective Binding to Soluble Type II IL-1 ReceptorPublished by Elsevier ,2002
- Anti–interleukin-1 therapy in rheumatic diseasesCurrent Opinion in Rheumatology, 2001
- Molecular Cloning and Expression of Cynomolgus Monkey Interleukin -1β cDNAInternational Archives of Allergy and Immunology, 1998
- Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor AntagonistInternational Reviews of Immunology, 1998
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994
- Prevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40Science, 1993
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITISPublished by Elsevier ,1988